-
- Reimbursement Consulting, Healthcare Business Solutions
- Healthcare Market Research
- Healthcare Education, Healthcare Education And Training
- Hotline Assessments and Patient Assistance Programs
- Expanded Access Program
- Case Studies
- Market Research - Leveraging insight from Payors
- Comparative Cost Analysis - Pharmaceuticals
- Healthcare Reform Analysis
- Health Technology Assessment - Oncology
- Reimbursement Call Center and Patient Assistance Program Design - Multiple Product Classes
- Comparative Effectiveness Review - Diabetes
- Reimbursement Training and Field Reimbursement Call Tracking Tool
- Competitive Intelligence - Urology
- Product Commercialization and Reimbursement Landscape Analysis - Oncology
- Clinical Services Evaluation - Specialty Pharmacy
- Commercialization Strategy - Deep Vein Thrombosis
- Coverage Analysis - Drug Delivery System
- Reimbursement Coverage and Coding Analysis - Vascular Stents
- Health Economic Analysis - Rheumatoid Arthritis
- Health Economics Analysis - Diabetes Mellitus Blood Glucose Monitoring
- Expanded Access
- Comprehensive Clinical Analysis and Clinical Protocol Design - Migrane
- Outcomes Research Plan - Gastroenterology
- Clinical Compendium and Gap Analysis - Pain Management
- Reimbursement Landscape Analysis - Rare Bleeding Disorders (Hemophilia)
- Disease Area Review and Burden of Illness Analysis - Oncology
- Hospital Inpatient Payor Claims Analysis - Hospital Acquired Infections
- Health Economic Analysis - Orthopedics
- Market Valuation - Opioids
- Meta Analysis - HIV (Human Immunodeficiency Virus)
- AMCP Dossier - Dermatology
- Competitive Intelligence - Infectious Diseases
- Competitive Intelligence - Contraception
- Reimbursement Landscape Analysis - Urology
- Health Economics Analysis - Crohn's Disease
- Comprehensive Reimbursement and Health Economic Analysis - Neurovascular Disease
- Patient Assistance Program Design - Insulin Products
- Health Technology Assessment - Wound Therapy System
Case Studies
Clinical Compendium and Gap Analysis - Pain Management
Insight
One of the fastest growing medical device companies invested significantly in multiple technology platforms that relied on spinal cord stimulation (SCS) to treat a myriad of pain syndromes. Despite growing experience with SCS, there remained significant questions about efficacy. In order to increase provider awareness of the clinical evidence supporting the use of spinal cord stimulation for the treatment of failed back surgery syndrome, The Aequitas Group was enlisted to develop a clinical compendium and gap analysis report.Strategy
The Aequitas Group conducted a systematic literature review. The goal was to find data in support of spinal cord stimulation regarding: side effects, adverse outcomes, costs, enhanced functional abilities and psychological well-being. The Aequitas Group used these results to develop a clinical and economic compendium.Execution
The client developed the compendium into a tool used by field-based medical liaisons and sales personnel in their efforts to communicate the value messages and to support their clinical and economic evidence.© 2009 The Aequitas Group, Inc. All Rights Reserved.